Missing Data for an Evidence-Based Approach to the Treatment of a Patent Ductus Arteriosus A Small Selection of What We Do not Know Yet

Author(s):  
Axel Franz
2014 ◽  
Vol 4 (3) ◽  
pp. 181-185
Author(s):  
Senka Mesihović Dinarević ◽  
Almira Kadic ◽  
Zijo Begić ◽  
Mirza Halimić ◽  
Emina Vukas

 Introduction: Transcatheter closure is a treatment choice for the most children with patent ductus arteriosus (PDA). The closure of the ductus is indicated in any child or adolescent with developed symptoms of significant L-R shunt. The aim of this article is to present our results in 5 years treatment of patients with PDA and their outcome. Methods: From 2009 to 2014, 30 patients underwent a transcatheter closure of PDA at Centre for Heart and Pediatric clinic of Clinical University Centre of Sarajevo. Aortic angiogram was performed to evaluate the size, position, and shape of the duct for selection of appropriate occluder device type and size. All procedures were performed by local team of cardiologists from the Department of Cardiology, Pediatric clinic, with invasive cardiologists team from Sweden and Austria. Echocardiography was repeated at intervals of 24 hours, then 1month, 3 months, and 1 year after the procedure to assess the outcome. Results: Thirty patients underwent transcatheter closure of PDA during the study period. PDA of ≤ 2.0 mm was present in 8 patients and they underwent PDA closure with coils, while 22 patients had PDA diameter  ≥ 2 mm, and they were treated by Amplatzer duct occluder (ADO). Only in 2 (6.2%) patients complications have been observed. The length of hospital stay after the treatment was two to three days. Conclusion: Transcatheter closure of PDA is a modern, safe and efficient method that ensures a faster recovery of the patients, shortens the length of hospitalization.


2021 ◽  
Vol 9 (04) ◽  
pp. 236-242
Author(s):  
Ammar M.H. Shehadeh ◽  
◽  
MHD Bilal Alkhawam ◽  
Amjad Mohamed Haider ◽  
◽  
...  

Patent ductus arteriosus (PDA) is a frequent congenital heart defect. It becomes even more common in preterm infants with a high burden of consequences and adverse effects. Recently, the emergence of a constellation of different management protocols urged for a comprehensive summery of the best evidence-based interventions. A detailed electronic search for evidence was carried out, including Cochrane, systemic and narrative reviews. Variable controversial aspects of PDA diagnosis and management were discussed. Brief echocardiographic and laboratory PDA diagnosis followed by a review of symptomatic and asymptomatic PDA Surgical and nonsurgical management strategies included. Early interventionfor asymptomatic PDA depending on echo scoring, and grading all symptomatic PDAs clinically and echographically can guide management and decrease the need for surgical ligation.


2021 ◽  
Vol 18 (2) ◽  
pp. 45-48
Author(s):  
Manish Shrestha ◽  
Urmila Shakya ◽  
Poonam Sharma ◽  
Subhash Shah ◽  
Shilpa Aryal ◽  
...  

Background and Aims: Two dimensional transthoracic echocardiography (2DE) is widely used for detecting congenital heart disease and is possible to obtain precise measurement of Patent ductus arteriosus (PDA) for device selection required for transcatheter closure. Primary aim of the study is to determine whether echocardiographic assessment alone can be used for selection of device for transcatheter closure of PDA. Methods: Children with PDA and planned for transcatheter intervention were included in this cross-sectional study of one year. PDA was assessed with 2DE and prediction of device size was made. Results: The results were obtained from 107 children. The median age and weight at intervention were 3.8 years (ranging from 6 months to14 years) and 12 kg (ranging from 3.5 to 60 kg). Type A (Conical) PDA was the commonest PDA morphology accounting for 87.8% and 85% in 2DE and angiography respectively. There was no difference (p < 0.05) in the narrowest diameter at pulmonary end measured by 2DE and angiography, however ampulla diameter and ductal length were statistically different (p = 0.95). The predicted size of device by 2DE was discordant (p < 0.05) to the actual device used in a total study population, however when patients with severe pulmonary hypertension, non-type A and larger PDA (narrowest diameter > 6mm) were excluded, the predicted size of device by 2DE was statistically concordant (p = 0.1) to the actual device used in 89 (83%) patients. Conclusion: Two dimensional Transthoracic echocardiography alone may be helpful in choosing the device during transcatheter closure of PDA in selective group of patients.


2020 ◽  
Vol 07 (03) ◽  
pp. 105-108
Author(s):  
Chandrakala Bada Shekharappa ◽  
Edison Albert Balakrishnan Elizabeth ◽  
Bharathi Balachander

Sign in / Sign up

Export Citation Format

Share Document